Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Sterling Silver St. Francis Of Assisi Medallion
Popular Articles

Human Genome Sciences Reports Positive Long-Term Data For BENLYSTA(TM) (Formerly LymphoStat-B(R)) In Patients With Active Systemic Lupus Erythematosus
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced the presentation of results from a long-term Phase 2 continuation trial showing that BENLYSTA(TM) (belimumab, formerly LymphoStat-B(R)) was associated with sustained improvement in disease activity across multiple clinical measures, decreased frequency of disease flares, and was generally well tolerated through four years on treatment in combination with standard of care in patients with serologically active systemic lupus erythematosus (SLE). The results were presented today in Copenhagen at the 2009 Congress of the European League Against Rheumatism (EULAR).
Aubade Bahia Tatoo Full Cup
150 Days: Obama's Silence On AIDS Remains Deafening
On the observation of President Obama"s first 150 days in office, AIDS Healthcare Foundation (AHF), the nation"s largest AIDS organization, is continuing its "Change AIDS Obama" campaign with the release of a new online advocacy video chastising the president for his ongoing-and baffling-silence on AIDS.
News of the day
Landmark Study For GSK's Cervical Cancer Vaccine Published In The Lancet
The final analysis of the largest efficacy trial of a cervical cancer vaccine is published today in The Lancet. The study, involving 18,644 women, confirmed GlaxoSmithKline"s Cervarix(R) is highly effective at protecting against the two most common cervical cancer-causing human papillomavirus (HPV) types, 16 and 18. The study also showed that the vaccine provides cross-protection against HPV types 31, 33 and 45, the three most common cancer-causing virus types beyond 16 and 18.
Public Health

New Taxes Could Help Pay For Reform, But Would Cost Political Capital

Two new taxes that could help pay for health care reform both carry political baggage. The first, a possible new tax on at least some employer-sponsored health benefits, has support from members of Congress on both sides of the aisle. But during last year"s presidential campaign, President Obama spoke out strongly against just such a plan when his opponent, Sen. John McCain suggested it, Roll Call reports. "Within weeks, Obama may find himself hawking around the country legislation that includes a provision he so ardently rejected during the campaign. Obama didn"t just oppose the exclusion. He all but drew a "read my lips" line in the sand ... "For the first time in American history, [McCain] wants to tax your health benefits," Obama said on the campaign trail. "Apparently, Sen. McCain doesn"t think it"s enough that your health premiums have doubled"" (Koffler, 6/4). Also sticky is a proposed new levy on soda, beer and wine that the Senate Finance Committee says would restrict the use of unhealthy products while at the same time raising money for health reform, the Associated Press reports. However, "Advertisers, corn refiners - even addiction treatment centers - have mobilized their lobbyists, reflecting how a tax increase for a handful of popular products can reverberate broadly across Washington"s interest groups" (Fram, 6/3). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009